MERLINO, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 5.510
AS - Asia 4.123
EU - Europa 2.066
SA - Sud America 729
AF - Africa 96
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 7
Totale 12.542
Nazione #
US - Stati Uniti d'America 5.411
SG - Singapore 2.277
CN - Cina 697
BR - Brasile 542
UA - Ucraina 439
IT - Italia 365
HK - Hong Kong 362
VN - Vietnam 334
DE - Germania 283
FI - Finlandia 211
RU - Federazione Russa 197
FR - Francia 188
IE - Irlanda 84
AR - Argentina 72
GB - Regno Unito 67
KR - Corea 66
IN - India 65
CA - Canada 50
SE - Svezia 46
BD - Bangladesh 43
IQ - Iraq 42
TR - Turchia 40
NL - Olanda 39
ZA - Sudafrica 36
ID - Indonesia 33
EC - Ecuador 30
AT - Austria 27
PK - Pakistan 27
MX - Messico 26
PL - Polonia 26
CO - Colombia 22
ES - Italia 21
JP - Giappone 21
UZ - Uzbekistan 19
VE - Venezuela 18
PY - Paraguay 16
BE - Belgio 15
SA - Arabia Saudita 14
MA - Marocco 13
IR - Iran 12
PH - Filippine 12
CL - Cile 11
TG - Togo 11
LT - Lituania 10
EU - Europa 9
PE - Perù 9
CZ - Repubblica Ceca 8
EG - Egitto 7
CH - Svizzera 6
KE - Kenya 6
AU - Australia 5
AZ - Azerbaigian 5
CR - Costa Rica 5
DZ - Algeria 5
ET - Etiopia 5
IL - Israele 5
JO - Giordania 5
MY - Malesia 5
NP - Nepal 5
PS - Palestinian Territory 5
RS - Serbia 5
UY - Uruguay 5
AL - Albania 4
AM - Armenia 4
KG - Kirghizistan 4
RO - Romania 4
BH - Bahrain 3
BO - Bolivia 3
GR - Grecia 3
HN - Honduras 3
KZ - Kazakistan 3
LV - Lettonia 3
PT - Portogallo 3
SN - Senegal 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
BZ - Belize 2
GA - Gabon 2
GT - Guatemala 2
KH - Cambogia 2
LB - Libano 2
LI - Liechtenstein 2
LU - Lussemburgo 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BJ - Benin 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
CD - Congo 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GD - Grenada 1
GE - Georgia 1
GY - Guiana 1
Totale 12.524
Città #
Singapore 852
Ashburn 520
Fairfield 463
Woodbridge 462
Ann Arbor 385
Hong Kong 348
Beijing 315
Jacksonville 309
Houston 307
Chandler 284
Wilmington 202
San Jose 190
Cambridge 167
Dearborn 164
Seattle 150
Boardman 135
Lauterbourg 129
Ho Chi Minh City 107
Los Angeles 99
Princeton 89
Dublin 82
Hanoi 70
São Paulo 64
Hefei 62
Seoul 62
Buffalo 60
Dallas 59
New York 58
Council Bluffs 52
Helsinki 51
Redondo Beach 47
Munich 40
Frankfurt am Main 35
San Diego 32
Orem 29
Udine 29
Ogden 28
Trieste 28
Izmir 27
Venezia 26
Tavagnacco 25
Milan 24
Norwalk 24
Johannesburg 23
Nuremberg 23
The Dalles 23
Guangzhou 22
Warsaw 22
Dong Ket 20
Tokyo 19
Ottawa 18
Buenos Aires 17
Rio de Janeiro 17
Santa Clara 17
Stockholm 17
Rome 16
Tashkent 16
Atlanta 15
Des Moines 15
London 15
Amsterdam 14
Boston 14
Brooklyn 14
Chicago 14
Da Nang 14
Denver 14
Düsseldorf 14
Brasília 13
Brussels 13
Codroipo 13
Haiphong 12
Montreal 12
Mumbai 12
Phoenix 12
Shanghai 12
Vienna 12
Lomé 11
Mexico City 11
Nanjing 11
Quito 11
Baghdad 10
Kunming 10
Lappeenranta 10
Poplar 10
Hyderabad 9
Lahore 9
San Pietro Mussolino 9
Toronto 9
Asunción 8
Biên Hòa 8
Changsha 8
San Francisco 8
Shenzhen 8
Thái Nguyên 8
Turku 8
Bogotá 7
Chennai 7
Curitiba 7
Dhaka 7
Guayaquil 7
Totale 7.426
Nome #
Restless legs syndrome: diagnosis, epidemiology, classification and consequences. 256
Restless legs syndrome: differential diagnosis and management with rotigotine 253
ADMET considerations when prescribing novel therapeutics to treat restless legs syndrome 178
Gabapentin Enacarbil in Restless Legs Syndrome 166
A case-control study on restless legs syndrome in nondialyzed patients with chronic renal failure 165
Pharmacokinetic drug evaluation of lacosamide for the treatment of partial-onset seizures 163
ADMET considerations for restless leg syndrome drug treatments. 161
Association of body rolling, leg rolling, and rhythmic feet movements in a young adult: A video-polysomnographic study performed before and after one night of clonazepam. 159
The use of rotigotine in the treatment of restless legs syndrome. 156
Anticholinergic drugs and neuropsychiatry symptoms in Alzheimer’s disease 153
Are sleep disorders able to increase cardiovascular risk in continuous ambulatory peritoneal dialysis (CAPD) patients ? 153
Clinical experience with pramipexole in the treatment of restless legs syndrome 150
Opioids in the treatment of restless legs syndrome: pharmacological and clinical aspects 150
Changes in hemodynamics during isoflurane and propofol anesthesia: a comparison study. 145
Timing use of novel anti-epileptic drugs: is earlier better? 145
Lacosamide for the treatment of epilepsy 143
The Acute Effect of a Low Dosage of Pramipexole on Severe Idiopathic Restless Legs Syndrome: An Open-Label Trial. 142
Efficacy and Safety of Intravenous Thrombolysis in Patients with Acute Ischemic Stroke and Pre⁻Existing Disability 138
Investigational approaches to therapies for restless legs syndrome 137
Are sleep disorders able to Increase cardiovascular risk in chronic hemodialyzed patients (CHP) ? 136
Drugs with anticholinergic properties as a risk factor for psychosis in patients affected by Alzheimer's disease 136
Pharmacotherapy of restless legs syndrome with pramipexole 132
Multicenter case-control study on restless legs syndrome in multiple sclerosis: the REMS study. 130
Sleep disorders in patients with end-stage renal disease undergoing dialysis therapy 129
Non-REM hypnic headache: a circadian disorder? A clinical and polysomnographic study 122
Brady Arrhythmia and sinus arrest in REM sleep 121
Restless legs syndrome in dialysis patients: a comparison between hemodialysis and continuous ambulatory peritoneal dialysis 121
Daytime Sleepiness is Associated with Dementia and Cognitive Decline in Older Italian Adults. A population-based study 120
Predictors of futile recanalization after intravenous thrombolysis in stroke patients transferred for endovascular treatment 119
Sarcoidosis as risk factor for cryptococcal meningitis in an apparently immunocompetent patient 118
Seizures with prolonged EEG abnormalities during an attack of migraine without aura. 115
Predictors of atrial fibrillation detection in embolic stroke of undetermined source patients with implantable loop recorder 114
Association between Restless Legs Syndrome and type 2 diabetes: a case control study. 114
Sleep-related movement disorders. 113
Anti-neuropil antibodies in a patient with limbic encephalitis and breast cancer 111
­Sleep fragmentation and cerebrovascular risk factors 111
Incidence of early poststroke seizures during reperfusion therapies in patients with acute ischemic stroke: An observational prospective study: (TESI study: "Trombolisi/Trombectomia e crisi Epilettiche precoci nello Stroke Ischemico") 110
­ Motor patterns of alien limb in different vigilance states: recording of periodic limb movement during wakefulness vs. sleep in a patient with Corticobasal degeneration (CBD) 108
Age-Specific Differences in Inflammatory Biomarkers and Their Impact on Futile Recanalization After Mechanical Thrombectomy: An Inverse Probability Weighting Analysis 107
Association between restless legs Syndrome and type 2 diabetes and consequences on quality of life and on psychological status: a case-control study 107
Sensory gating deficit assessed by the P50 midlatency auditory evoked potential in untreated patients with Alzheimer’s Disease (AD): correlation with NeuroPsychiatric Symptoms (NPS) and modifications induced by the Cholinesterase Inhibitor (CHEI) done 106
Response to restless legs syndrome and diabetic neuropathy--commentary by Gemignani, et al 105
Posterior Reversible Encephalopathy Syndrome in Guillain-Barré Syndrome: Just a Problem of Immunoglobulins? Controversy From Two Atypical Case Reports 105
­Alternating leg muscle activation (ALMA) with excessive daytime sleepiness 102
Bereitshaftpotential and fatigue in recently diagnosed SM patients 102
Event – Related Potential ERP) P300 in chronic vascular hemiparetic patients 101
Insomnia and daytime sleepiness predict 20-year mortality in older male adults: data from a population-based study 101
Safety and Outcomes of Mechanical Thrombectomy in Acute Ischemic Stroke Attributable to Cardiological Diseases: A Scoping Review 100
A comprehensive update on the ADMET considerations for α2δ calcium channel ligand medications for treating restless legs syndrome 100
2:1 ketogenic diet and low-glycemic-index diet for the treatment of chronic and episodic migraine: a single-center real-life retrospective study 100
­Non-REM hypnic headache: a circadian disorder? A clinical and polysomnographic study 100
Prevalence of “poor sleep” among patients with multiple sclerosis: An independent predictor of mental and physical status 100
Do sleep disorders start in dialysis or in early chronic kidney disease? Reply 99
Botulinum Toxin Type A for Trigeminal Neuralgia: A Comprehensive Literature Review 98
Prevalence of sleep disorders in patients with end-stage renal disease undergoing dialysis therapy 98
Prevalence and impact on quality of life of sleep disturbance among patients affected by multiple sclerosis. 98
The effect of drugs with anticholinergic activity on cognitive and neuropsychiatric symptoms in Alzheimer disease 98
Sleep paralysis and hallucinations 97
When Nothing Goes Right: An Unexpected Tongue Deviation in Internal Carotid Artery Dissection 97
Seizures Do Not Affect Disability and Mortality Outcomes of Stroke: A Population-Based Study 95
Ketogenic diet may improve sleep quality and daytime somnolence in patients affected by multiple sclerosis. Results of an exploratory study 94
Sensory gating deficit assessed by P50/Pb middle latency event related potential in Alzheimer’s disease 94
Lower lymphocyte counts and older age are associated with reduced multiple sclerosis disease activity during dimethyl fumarate treatment 93
Impact of atrial fibrillation on outcomes in stroke patients with tandem occlusions treated with thrombectomy: A multicentre study 92
The Possible Precipitating Role of SARS-CoV-2 in a Case of Late-Onset Hemichorea Due to a Hyperosmolar Hyperglycemic State: Case Report and Brief Literature Review 92
­ Prevalence of “poor sleep” among patients with multiple sclerosis: an independent predictor of mental and physical status 92
Restless legs syndrome in chronic hemodyalized patients: preliminary data 91
La sindrome delle gambe senza riposo nel paziente nefropatico 91
Current and emerging pharmaceutical strategies for the treatment and management of restless legs syndrome 89
. Ottimizzazione della terapia farmacologia con pregabalin in un paziente con epilessia ed alterazioni del sonno notturno (sindrome delle gambe senza riposo) 89
­Effetti acuti di basse dosi di pramipexolo in pazienti affetti da Sindrome delle gambe senza riposo severa idiopatica 88
Recanalisation theraphy for acute ischemic stroke in cancer patients 88
Seizures after ischemic stroke: a matched multicenter study 88
Effects of restless legs syndrome on quality of life ad psychological status in patients with type 2 diabetes 86
The use of alteplase, although safe, does not offer clear clinical advantages when mild stroke is non-disabling 86
Association of Mortality and Risk of Epilepsy With Type of Acute Symptomatic Seizure After Ischemic Stroke and an Updated Prognostic Model 85
Stress Hyperglycemia Does Not Affect Clinical Outcome of Diabetic Patients Receiving Intravenous Thrombolysis for Acute Ischemic Stroke 84
Trattamento farmacologico della sindrome delle gambe senza riposo con farmaci non-dopaminoagonisti 84
To Treat or Not to Treat: Importance of Functional Dependence in Deciding Intravenous Thrombolysis of "Mild Stroke" Patients 84
Stress hyperglycemia is predictive of worse outcome in patients with acute ischemic stroke undergoing intravenous thrombolysis 84
­The predictive value of mini-mental state examination as dementia screening tool in general medical practice 83
Stress Hyperglycemia in Patients With Acute Ischemic Stroke Due to Large Vessel Occlusion Undergoing Mechanical Thrombectomy 83
Outcomes of different anesthesia techniques in nonagenarians treated with mechanical thrombectomy for anterior circulation large vessel occlusion: An inverse probability weighting analysis 82
Post-Stroke Status Epilepticus: Time of Occurrence May Be the Difference? 82
­Patologie ipofisarie e sonno 81
Gabapentin enacarbil, a gabapentin prodrug for the treatment of the neurological symptoms associated with disorders such as restless legs syndrome 81
Neuroinvasive west nile infection with an unusual clinical presentation: a single-center case series 81
­Sindrome delle gambe senza riposo: tra certezze e controversie 80
Restless leg syndrome in dalysis patients 80
Prior Use of Antiplatelet Therapy and Outcomes after Endovascular Therapy in Acute Ischemic Stroke Due to Large Vessel Occlusion: A Single-Center Experience 80
Dynamic Hyperglycemic Patterns Predict Adverse Outcomes in Patients with Acute Ischemic Stroke Undergoing Mechanical Thrombectomy 80
Short and long-term outcomes after combined intravenous thrombolysis and mechanical thrombectomy versus direct mechanical thrombectomy: a prospective single-center study 79
­Event-Related Potential (ERP) P300 in chronic vascular hemiparetic patients 79
Filtro neurosensoriale e disturbi psichico-comportamentali nei malati di Alzheimer: studio in aperto con Donepezil 79
La sindrome delle gambe senza riposo nei pazienti emodializzati cronici 79
Sleep of migraine patients is ameliorated by ketogenic diet, independently of pain control 77
­Disturbi del sonno in pazienti affetti da insufficienza renale cronica sottoposti a terapia dialitica 75
Sleep disturbances in dialysis patients 73
La sindrome delle gambe senza riposo nei pazienti affetti da insufficienza renale non dializzati (dati preliminari). 72
Rivastigmine versus Donepezil in clinical pratice: an observational study 72
Totale 10.961
Categoria #
all - tutte 48.826
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.826


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021176 0 0 0 0 0 0 0 0 0 20 109 47
2021/2022636 19 64 34 46 15 46 18 41 9 103 133 108
2022/2023696 97 39 17 74 74 207 3 44 70 7 30 34
2023/2024395 38 22 31 10 27 36 7 40 44 71 9 60
2024/20252.906 40 138 110 99 221 126 140 130 311 238 561 792
2025/20264.413 397 462 464 555 729 353 522 219 333 379 0 0
Totale 12.905